Cited 0 times in
Intramuscular triamcinolone acetonide: An undervalued option for refractory alopecia areata
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이영인 | - |
dc.contributor.author | 김도영 | - |
dc.contributor.author | 황신원 | - |
dc.date.accessioned | 2021-07-14T00:39:15Z | - |
dc.date.available | 2021-07-14T00:39:15Z | - |
dc.date.issued | 2017-02 | - |
dc.identifier.issn | 0385-2407 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/183001 | - |
dc.description.abstract | Severe alopecia areata (AA) can have an unpredictable clinical course and become refractory to contact immunotherapy. Novel treatment options include low-dose interleukin-2 and Janus kinase inhibitors; however, these treatments are still under investigation. Therefore, we evaluated the efficacy and safety of intramuscular (i.m.) triamcinolone acetonide (TAC) as a rescue therapy for refractory AA. We retrospectively analysed efficacy, adverse effects and relapse rate of i.m. TAC monthly in 27 patients with refractory AA. We defined AA as refractory if the patient showed an unsatisfactory response to both systemic treatment (not i.m. TAC) and the consecutive diphenylcyclopropenone immunotherapy. The initial systemic treatment of other forms of corticosteroids and/or cyclosporin was used to control extensive AA involving more than 25% of the scalp. Administration of i.m. TAC for 3-6 months resulted in a 63.0% response rate, and all patients showed inactive disease after treatment. Final hair regrowth negatively correlated with initial scalp involvement (Spearman r = -0.595, P = 0.001). All patients showed complete recovery of adrenocortical reserve within 3 months after the last injection. Adverse effects of systemic steroid therapy were observed only in female patients (dysmenorrhea and osteoporosis). i.m. TAC may provide a valuable therapeutic option to manage active hair loss and facilitate hair regrowth in refractory AA, especially in male patients. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Wiley-Blackwell | - |
dc.relation.isPartOf | JOURNAL OF DERMATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Alopecia Areata / drug therapy* | - |
dc.subject.MESH | Child | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Glucocorticoids / administration & dosage* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Injections, Intramuscular | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Triamcinolone Acetonide / administration & dosage* | - |
dc.subject.MESH | Young Adult | - |
dc.title | Intramuscular triamcinolone acetonide: An undervalued option for refractory alopecia areata | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Dermatology (피부과학교실) | - |
dc.contributor.googleauthor | Jimyung Seo | - |
dc.contributor.googleauthor | Young In Lee | - |
dc.contributor.googleauthor | Shinwon Hwang | - |
dc.contributor.googleauthor | Zhenlong Zheng | - |
dc.contributor.googleauthor | Do Young Kim | - |
dc.identifier.doi | 10.1111/1346-8138.13533 | - |
dc.contributor.localId | A05880 | - |
dc.contributor.localId | A00384 | - |
dc.contributor.localId | Y0196335 | - |
dc.relation.journalcode | J01372 | - |
dc.identifier.eissn | 1346-8138 | - |
dc.identifier.pmid | 27448451 | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.13533 | - |
dc.subject.keyword | adverse effects | - |
dc.subject.keyword | alopecia areata | - |
dc.subject.keyword | intramuscular triamcinolone acetonide | - |
dc.subject.keyword | relapse | - |
dc.subject.keyword | steroids | - |
dc.contributor.alternativeName | Lee, Young In | - |
dc.contributor.affiliatedAuthor | 이영인 | - |
dc.contributor.affiliatedAuthor | 김도영 | - |
dc.contributor.affiliatedAuthor | 황신원 | - |
dc.citation.volume | 44 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 173 | - |
dc.citation.endPage | 179 | - |
dc.identifier.bibliographicCitation | JOURNAL OF DERMATOLOGY, Vol.44(2) : 173-179, 2017-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.